ZNTL SCHEDULE 13G/A: SEC filing

5AM Opportunities entities and associated individuals

Filed with the SEC on · accession 0001873515-26-000003

ZNTL filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Nov 16, 2026. 5AM Opportunities entities and associated individuals filed an amended Schedule 13G reporting beneficial ownership of Zentalis Pharmaceuticals common stock as of September 30, 2026, with Kush Parmar and Andrew J. The stock moved -5.6% by the first close after the filing.

Summary of the filing

5AM Opportunities entities and associated individuals filed an amended Schedule 13G reporting beneficial ownership of Zentalis Pharmaceuticals common stock as of September 30, 2026, with Kush Parmar and Andrew J. Schwab each reporting beneficial ownership of 5,157,742 shares (5.3%).

Key details

Shares beneficially owned by 5AM Opportunities II, L.P.$3.9M
Shares beneficially owned by 5AM Opportunities Master Fund, L.P.$577K
Shares held by separately managed account$633K
Aggregate shares beneficially owned by Kush Parmar and Andrew J. Schwab$5.2M
Aggregate shares beneficially owned by Anna Yaeger$1.2M
IssuerZentalis Pharmaceuticals, Inc.
Reporting person / general partner5AM Opportunities II (GP), LLC
Reporting person / direct holder5AM Opportunities II, L.P.
Reporting person / general partner5AM Opportunities (GP), LLC
Reporting person / direct holder5AM Opportunities Master Fund, L.P.
Reporting person / investment adviser5AM Opportunities Management, L.P.
Managing member of 5am opportunities gp entitiesKush Parmar
Managing member of 5am opportunities gp entitiesAndrew J. Schwab
Managing member of 5am opportunities gp entitiesAnna Yaeger

How ZNTL stock reacted

Close before

$1.70

Nov 13, 2026

First close after

-5.59%

$1.60

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for ZNTL, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for ZNTL?

Click here

Frequently asked questions

What did ZNTL file with the SEC on Nov 16, 2026?

ZNTL filed a SCHEDULE 13G/A (SEC filing). 5AM Opportunities entities and associated individuals filed an amended Schedule 13G reporting beneficial ownership of Zentalis Pharmaceuticals common stock as of September 30, 2026, with Kush Parmar and Andrew J. Schwab each reporting beneficial ownership of 5,157,742 shares (5.3%).

How do I read a SCHEDULE 13G/A?

A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).

How did ZNTL stock react to this filing?

ZNTL closed at $1.70 before the filing and $1.60 on Nov 16, 2026 (-5.59%).

Other ZNTL SEC filings

Get alerts when ZNTL files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days